Latest Insider Transactions at Vir Biotechnology, Inc. (VIR)
This section provides a real-time view of insider transactions for Vir Biotechnology, Inc. (VIR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vir Biotechnology, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vir Biotechnology, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2025
|
Mark Eisner EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,586
-3.31%
|
$17,930
$5.47 P/Share
|
|
Jul 15
2025
|
Mark Eisner EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,796
-5.91%
|
$33,980
$5.47 P/Share
|
|
Jul 01
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
22,000
-1.67%
|
$110,000
$5.1 P/Share
|
|
Jun 09
2025
|
Robert J More Director |
BUY
Other acquisition or disposition
|
Indirect |
14,027
+2.68%
|
-
|
|
Jun 09
2025
|
Robert J More Director |
SELL
Other acquisition or disposition
|
Direct |
14,027
-25.65%
|
-
|
|
Jun 06
2025
|
Norbert W Bischofberger Director |
BUY
Other acquisition or disposition
|
Indirect |
10,667
+50.0%
|
-
|
|
Jun 06
2025
|
Norbert W Bischofberger Director |
SELL
Other acquisition or disposition
|
Direct |
10,667
-44.45%
|
-
|
|
Jun 02
2025
|
Janet Napolitano Director |
SELL
Open market or private sale
|
Direct |
3,200
-16.31%
|
$16,000
$5.05 P/Share
|
|
May 30
2025
|
Charles Elliott Sigal Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+20.1%
|
-
|
|
May 30
2025
|
Janet Napolitano Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+28.97%
|
-
|
|
May 30
2025
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+26.13%
|
-
|
|
May 30
2025
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+0.6%
|
-
|
|
May 30
2025
|
Jeffrey S. Hatfield Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+20.1%
|
-
|
|
May 30
2025
|
Robert J More Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+12.76%
|
-
|
|
May 30
2025
|
Norbert W Bischofberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.0%
|
-
|
|
May 30
2025
|
Ramy Farid Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.0%
|
-
|
|
Apr 03
2025
|
Marianne De Backer Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
79,712
-9.39%
|
$398,560
$5.95 P/Share
|
|
Feb 26
2025
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
7,373
-8.49%
|
$66,357
$9.14 P/Share
|
|
Feb 24
2025
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
10,056
-1.42%
|
$90,504
$9.45 P/Share
|
|
Feb 24
2025
|
Ann M. Hanly EVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
14,168
-10.73%
|
$127,512
$9.45 P/Share
|
|
Feb 24
2025
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
5,140
-5.59%
|
$46,260
$9.45 P/Share
|
|
Feb 24
2025
|
Marianne De Backer Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,122
-1.86%
|
$145,098
$9.45 P/Share
|
|
Feb 24
2025
|
Brent Sabatini SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,562
-3.24%
|
$14,058
$9.45 P/Share
|
|
Feb 22
2025
|
Jason O'Byrne EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+25.81%
|
-
|
|
Feb 22
2025
|
Vanina De Verneuil EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+27.56%
|
-
|
|
Feb 22
2025
|
Marianne De Backer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
240,000
+21.71%
|
-
|
|
Feb 22
2025
|
Brent Sabatini SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+29.33%
|
-
|
|
Feb 22
2025
|
Mark Eisner EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+25.81%
|
-
|
|
Feb 18
2025
|
George A Scangos Director |
SELL
Open market or private sale
|
Direct |
10,964
-1.52%
|
$98,676
$9.81 P/Share
|
|
Feb 13
2025
|
Brent Sabatini SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,562
-5.25%
|
$14,058
$9.15 P/Share
|
|
Jan 08
2025
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
10,960
-0.83%
|
$131,520
$12.52 P/Share
|
|
Dec 02
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
76
-0.13%
|
$608
$8.22 P/Share
|
|
Nov 15
2024
|
Jason O'Byrne EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
|
Nov 06
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
4,397
-7.16%
|
$43,970
$10.11 P/Share
|
|
Nov 05
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
2,347
-3.68%
|
$21,123
$9.47 P/Share
|
|
Nov 01
2024
|
Vanina De Verneuil EVP and General Counsel |
SELL
Open market or private sale
|
Direct |
1,403
-2.15%
|
$9,821
$7.2 P/Share
|
|
Oct 23
2024
|
George A Scangos Director |
SELL
Other acquisition or disposition
|
Indirect |
1,196,540
-34.19%
|
-
|
|
Oct 23
2024
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Indirect |
598,270
+50.0%
|
-
|
|
Oct 23
2024
|
George A Scangos Director |
BUY
Other acquisition or disposition
|
Direct |
598,270
+45.41%
|
-
|
|
Sep 09
2024
|
Janet Napolitano Director |
SELL
Open market or private sale
|
Direct |
12,190
-51.21%
|
$85,330
$7.8 P/Share
|
|
Jul 15
2024
|
Mark Eisner EVP and Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
|
Jun 12
2024
|
Marianne De Backer Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
53,118
+50.0%
|
-
|
|
Jun 12
2024
|
Marianne De Backer Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
53,118
-7.83%
|
-
|
|
Jun 11
2024
|
Saira Ramasastry Director |
SELL
Open market or private sale
|
Direct |
4,000
-21.48%
|
$40,000
$10.95 P/Share
|
|
May 30
2024
|
Saira Ramasastry Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+30.05%
|
-
|
|
May 30
2024
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+0.6%
|
-
|
|
May 30
2024
|
George A Scangos Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+6.2%
|
-
|
|
May 30
2024
|
Charles Elliott Sigal Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.15%
|
-
|
|
May 30
2024
|
Robert Nelsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+1.35%
|
-
|
|
May 30
2024
|
Janet Napolitano Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+25.15%
|
-
|